Smithfield Trust’s Evolent Health EVH Stock Holding History

Smithfield Trust’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$383K	Buy	70,584 +67,849	+2,481%	+$260K	0.02%	283
2026 Q1	$6K	Buy	+2,735	New	+$8.68K	﹤0.01%	964
2021 Q1	–	Sell	-3,000	Closed	-$48K	–	1100
2020 Q4	$48K	Hold	3,000	–	–	﹤0.01%	531
2020 Q3	$37K	Hold	3,000	–	–	﹤0.01%	551
2020 Q2	$21K	Hold	3,000	–	–	﹤0.01%	615
2020 Q1	$16K	Buy	+3,000	New	+$26.8K	﹤0.01%	607
2017 Q3	–	Sell	-4,000	Closed	-$101K	–	811
2017 Q2	$101K	Hold	4,000	–	–	0.01%	408
2017 Q1	$89K	Hold	4,000	–	–	0.01%	425
2016 Q4	$59K	Hold	4,000	–	–	0.01%	490
2016 Q3	$98K	Hold	4,000	–	–	0.02%	389
2016 Q2	$77K	Hold	4,000	–	–	0.01%	427
2016 Q1	$42K	Buy	4,000 +2,000	+100%	+$20.7K	0.01%	508
2015 Q4	$24K	Buy	+2,000	New	+$29.5K	﹤0.01%	584

Other funds holding EVH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return

Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Smithfield Trust's EVH Position: Q2 2026 in Review

Smithfield Trust increased its Evolent Health (EVH) stake by 2,481% in Q2 2026, buying an estimated $260K and bringing the position to 70,584 shares worth $383K. The position accounts for 0.02% of the portfolio, ranked #283.

Smithfield Trust first reported a position in EVH in Q4 2015 and has held it in 13 quarters since. 198 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

Smithfield Trust held 70,584 shares of Evolent Health worth $383K as of Q2 2026.
Smithfield Trust bought 67,849 Evolent Health shares in Q2 2026, an estimated $260K.
Evolent Health made up 0.02% of Smithfield Trust's portfolio in Q2 2026, its #283 holding.
Smithfield Trust first reported a position in Evolent Health in Q4 2015 and has held it in 13 quarters since.
198 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Smithfield Trust's 13F filing for Q2 2026, filed 5 Aug 2026.